Ready Capital RC Slides to 178 Support and Resistance Levels in Focus Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces Better Home Finance BETR Rallies 4 as Buyers Push Toward Key Resistance Limbach Holdings LMB Holds Steady Near Support After Modest Decline Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals